Cargando…
EphA5 Silencing Increases the Radiosensitivity of ESCC Cells Through ATM-Dependent Pathway
BACKGROUND: Radiotherapy is one of the most important treatments for esophageal squamous cell carcinoma (ESCC). Previously, we found that EphA5 expression was increased in ESCC cells and tumor tissues. Studies from other groups reported that EphA5 is abnormally expressed in numerous malignant tumors...
Autores principales: | Zhang, Rui, Han, Dan, Li, Lu, Luo, Wenguang, Liu, Jing, Qian, Liting |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537809/ https://www.ncbi.nlm.nih.gov/pubmed/33061640 http://dx.doi.org/10.2147/CMAR.S261182 |
Ejemplares similares
-
EphA5 and EphA6: regulation of neuronal and spine morphology
por: Das, Gitanjali, et al.
Publicado: (2016) -
Ephrin Receptors (Eph): EphA1, EphA5, and EphA7 Expression in Uveal Melanoma—Associations with Clinical Parameters and Patient Survival
por: Gajdzis, Malgorzata, et al.
Publicado: (2020) -
The efficacy of receptor tyrosine kinase EphA2 autophosphorylation increases with EphA2 oligomer size
por: Zapata-Mercado, Elmer, et al.
Publicado: (2022) -
Vaccination with EphA2-derived T cell-epitopes promotes immunity against both EphA2-expressing and EphA2-negative tumors
por: Hatano, Manabu, et al.
Publicado: (2004) -
miR-26b enhances radiosensitivity of hepatocellular carcinoma cells by targeting EphA2
por: Jin, Qiao, et al.
Publicado: (2016)